NanoHarmonics, a pioneer in nanotechnology diagnostics, has partnered with Avagen Pharma, a Texas based nano-pharmaceutical company to further its mission in transforming healthcare through disruptive nanotechnology.
Avagen Pharma focuses on novel pharmaceutical products using a patented nanotechnology called NanoPro Rx™. NanoHarmonics utilizes a proprietary form of nanotechnology, Quantum Dots, called Abacus™ in their patented diagnostic platform. “Our focus is to use nanotechnology to create or improve pharmaceutical and diagnostics within healthcare. This is a great time to bring together our different nanotechnology platforms and use internal synergies between both companies to improve the efficacy, safety, and accessibility of certain healthcare products for people all over the world,” says Justin Jones, CEO of Avagen Pharma.
“Our collaboration with Avagen Pharma will allow us to truly revolutionize healthcare through practical applications of nanotechnology,” says Jimi Sta Maria, Chairman and CEO of NanoHarmonics. Both companies will be jointly headquartered in San Antonio, TX.
Read the original article on PRWeb.
